NPT200-11
CAS No. 2227057-23-8
NPT200-11 ( —— )
产品货号. M28510 CAS No. 2227057-23-8
NPT200-11 是一种口服生物可利用的脑穿透抑制剂,可抑制 α-突触核蛋白 (ASYN) 错误折叠和聚集的积累。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥3540 | 有现货 |
|
| 10MG | ¥5306 | 有现货 |
|
| 25MG | ¥9542 | 有现货 |
|
| 50MG | ¥14321 | 有现货 |
|
| 100MG | ¥21481 | 有现货 |
|
| 200MG | ¥32222 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称NPT200-11
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述NPT200-11 是一种口服生物可利用的脑穿透抑制剂,可抑制 α-突触核蛋白 (ASYN) 错误折叠和聚集的积累。
-
产品描述NPT200-11 is an orally bioavailable and brain penetrating inhibitor of accumulation of alpha-synuclein (ASYN) misfolding and aggregation. NPT200-11 can be used in studies about the underlying pathology of synucleinopathies including Parkinson's disease (PD), dementia with Lewy bodies (DLB) and Multiple Systems Atrophy (MSA).(In Vivo):In the Line 61 transgenic mouse model overexpressing human wild type ASYN, NPT200-11 (5 mg/kg; i.p.) results in a time-dependent and progressive reduction in retinal ASYN pathology. NPT200-11 reduced alpha-synuclein pathology in cortex, reduced associated neuroinflammation (astrogliosis), normalized striatal levels of the dopamine transporter (DAT) and improved motor function.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number2227057-23-8
-
分子量——
-
分子式——
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Itameline
RU 47213 can be used to inhibit scopolamine-induced working memory impairment in rats.
-
[Lys1015,1024]-Throm...
4N1K peptide 是一种有生物活性的肽。(源自血小板反应蛋白的 4N1K 肽 (KRFYVVMWKK) 对多种癌症具有抗癌活性)
-
Pinusolide
Pinusolide is a platelet activating factor ( PAF) antagonist, it may prove of therapeutic value in the treatment of hypotension, it has antileukemic potential, and could be used to treat neurodegenerative diseases.
021-51111890
购物车()
sales@molnova.cn

